Exane Derivatives’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.46M Sell
28,968
-533
-2% -$29K 0.84% 25
2022
Q1
$1.8M Sell
29,501
-1,124
-4% -$67K 0.51% 41
2021
Q4
$2.02M Buy
30,625
+28,259
+1,194% +$1.81M 0.49% 39
2021
Q3
$149K Buy
2,366
+2,300
+3,485% +$147K 0.04% 464
2021
Q2
$4.04K Hold
66
﹤0.01% 785
2021
Q1
$3.63K Hold
66
﹤0.01% 638
2020
Q4
$3.6K Hold
66
﹤0.01% 580
2020
Q3
$3.3K Hold
66
﹤0.01% 532
2020
Q2
$2.91K Sell
66
-4,290
-98% -$183K ﹤0.01% 481
2020
Q1
$164K Buy
+4,356
New +$183K 0.05% 221

Other funds holding IHI

Exane Derivatives's IHI Position: Q2 2022 in Review

Exane Derivatives reduced its iShares US Medical Devices ETF (IHI) stake by 1.8% in Q2 2022, selling an estimated $29K and leaving 28,968 shares worth $1.46M. The position accounts for 0.84% of the portfolio, ranked #25.

Exane Derivatives first reported a position in IHI in Q1 2020 and has held it in 10 quarters since. The position peaked at $2.02M in Q4 2021. 593 funds tracked by Wall St. Rank hold IHI as of Q2 2022.

  • Exane Derivatives held 28,968 shares of iShares US Medical Devices ETF worth $1.46M as of Q2 2022.
  • Exane Derivatives sold 533 iShares US Medical Devices ETF shares in Q2 2022, an estimated $29K.
  • iShares US Medical Devices ETF made up 0.84% of Exane Derivatives's portfolio in Q2 2022, its #25 holding.
  • Exane Derivatives first reported a position in iShares US Medical Devices ETF in Q1 2020 and has held it in 10 quarters since.
  • Exane Derivatives's iShares US Medical Devices ETF position peaked at $2.02M in Q4 2021.
  • 593 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.